China Resources Pharmaceutical : ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF JIANGZHONG PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in Hong Kong with limited liability)

(Stock Code: 3320)

ANNOUNCEMENT

UNAUDITED FINANCIAL RESULTS OF JIANGZHONG PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2021

On 23 April 2021, Jiangzhong Pharmaceutical released its quarterly report for the three months ended 31 March 2021.

Jiangzhong Pharmaceutical Co . , Ltd .（江中藥業股份有限公司）( " Jiangzhong Pharmaceutical") is a company incorporated in the People's Republic of China. The shares of Jiangzhong Pharmaceutical are listed on the Shanghai Stock Exchange. As of the date of this announcement, Jiangzhong Pharmaceutical is owned as to approximately 43.03% equity interest by China Resources Pharmaceutical Group Limited (the "Company", together with

its subsidiaries, the "Group") through its non-wholly owned subsidiary, China Resources Jiangzhong Pharmaceutical Group Co., Ltd（. 華潤江中製藥集團有限責任公司）. The Group controls an effective interest of approximately 21.95% of Jiangzhong Pharmaceutical, which

is accounted for as a subsidiary of the Company.

On 23 April 2021, Jiangzhong Pharmaceutical released its quarterly report for the three months ended 31 March 2021 (the "Jiangzhong Pharmaceutical Unaudited Financials"). In which, it announced that the net profit for the three months ended 31 March 2021 was RMB162,120,929.28, representing an increase of 20.75% as compared to the net profit of RMB134,263,675.74 for the same period last year.

1

Set out below are the key financial information of the Jiangzhong Pharmaceutical Unaudited Financials:

The Jiangzhong Pharmaceutical Unaudited Financials have been prepared in accordance with the PRC Generally Accepted Accounting Principles, have not been reviewed or audited by the Company's auditors, and may require adjustment during the course of auditing. The financial information is limited to Jiangzhong Pharmaceutical only and does not represent or provide a complete view of the operational or financial status of the Group. Shareholders and potential

investors should exercise caution when dealing in securities of the Company and should not rely solely on such information.

2

For further details of the Jiangzhong Pharmaceutical Unaudited Financials, please refer to the quarterly report for the three months ended 31 March 2021 published by Jiangzhong Pharmaceutical on the website of the Shanghai Stock Exchange (www.sse.com.cn).

By order of the Board of Directors

China Resources Pharmaceutical Group Limited

Wang Chuncheng

Chairman

Shenzhen, 26 April 2021

As of the date of this announcement, the Board comprises Mr. Wang Chuncheng as chairman and non-executive Director, Mr. Han Yuewei, Mr. Li Xiangming and Mdm. Weng Jingwen as executive Directors, Mr. Yu Zhongliang, Mdm. Guo Wei, Mr. Hou Bo and Mr. Qing Mei Ping Cuo as non-executive Directors and Mdm. Shing Mo Han Yvonne, Mr. Kwok Kin Fun, Mr. Fu Tingmei and Mr. Zhang Kejian as independent non-executive Directors.

3